Page last updated: 2024-11-03

prazosin and Carcinoma, Non-Small Cell Lung

prazosin has been researched along with Carcinoma, Non-Small Cell Lung in 2 studies

Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Robey, RW1
Obrzut, T1
Shukla, S1
Polgar, O1
Macalou, S1
Bahr, JC1
Di Pietro, A1
Ambudkar, SV1
Bates, SE1
Ke, Z1
Zhang, X1
Ma, L1
Wang, L1

Other Studies

2 other studies available for prazosin and Carcinoma, Non-Small Cell Lung

ArticleYear
Becatecarin (rebeccamycin analog, NSC 655649) is a transport substrate and induces expression of the ATP-binding cassette transporter, ABCG2, in lung carcinoma cells.
    Cancer chemotherapy and pharmacology, 2009, Volume: 64, Issue:3

    Topics: Adenosine Triphosphatases; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Mem

2009
Expression of DPC4/Smad4 in non-small-cell lung carcinoma and its relationship with angiogenesis.
    Neoplasma, 2008, Volume: 55, Issue:4

    Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Female; Humans; Immunohistochemistry;

2008